Clinical Trial

Sustainable and Efficient Platform Trial of New Therapeutic Development for Early Breast Cancer

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Randomized phase II trial targeting early-stage breast cancer (stage II-III) applicable to preoperative chemotherapy (NAC), comparing standard treatment with multiple experimental treatments.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-07-30; most recent amendment 2025-11-19.
Trial Details
NCT Number NCT06535893
Lead Sponsor Nagoya City University
Collaborators: Japan Clinical Oncology Group
Conditions Breast Cancer
Enrollment 100 participants
Start Date 2024-07-30
Primary Completion 2027-06-30 (estimated)
Study Completion 2040-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-11-20